18 Apr

Alamo Pharma Services, Inc.’s Peter Marchesini serves as chairperson of featured Patient Impact tract during the eyeforpharma 2018 meeting

DOYLESTOWN, Pa. (April 18, 2018) – Peter Marchesini, Chief Operating Officer of Alamo Pharma Services, Inc. (“Alamo”), recently participated as a “chairperson” of the “Patient Impact” tract panel discussions at the eyeforpharma 2018 meeting held in Philadelphia April 10-11. The annual gathering of more than 800 senior-level pharmaceutical executives encouraged inspiring and forward-thinking leaders from the pharmaceutical industry to share ideas, lessons learned, and case studies on how they have transformed insights from patients and customers into healthcare innovations...

27 Mar

Alamo Pharma Services partners with Thingee Corporation for deployment of their iDetail™ enterprise content delivery platform for iPad

DOYLESTOWN, Pa. (March 27, 2018) – Alamo Pharma Services (“Alamo”) and Thingee Corporation (“Thingee”) have announced a strategic partnership utilizing Thingee’s iDetail platform that will provide Alamo Pharma’s sales representatives quick, seamless access to their most current presentations, audio/video files, and PDFs developed as sales and detailing aids. This enhanced access will allow for heightened Alamo sales team productivity by assisting representatives in engaging with physicians and physician office staff members in more dynamic and effective ways.

“...

21 Mar

Alamo Pharma Services Training Team’s Article featured in the Life Sciences Trainers & Educators Network FOCUS on Training magazine

DOYLESTOWN, Pa. (March 21, 2018) – Alamo Pharma Services (“Alamo”), a well-known leader in sales training and recruiting for the pharmaceutical and biotech industries, has announced a heightened level of engagement with its membership in the Life Sciences Trainers & Educators Network (“LTEN”). As part of this increased commitment to that organization, the Alamo sales training team has contributed a feature article for the spring edition of LTEN Focus on Training magazine.

The article, titled “Increasing Engagement,” was written by Alamo sales training...

1 Mar

Alamo Pharma Services recognized by Training magazine as a 2018 Training Top 125 winner

DOYLESTOWN, Pa. (February 28, 2018) – Alamo Pharma Services (“Alamo”) was recently recognized as one of Training magazine’s annual Training Top 125, that ranks companies’ excellence in employer-sponsored training and development programs. The rankings were unveiled during an awards gala held in conjunction with the recent Training 2018 Conference and Expo in Atlanta.

“Receiving this recognition from Training magazine, a true ‘go-to resource’ for all industries, is an exciting honor for the team at Alamo,” says Peter Marchesini, Chief Operating...

21 Feb

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

SAN ANTONIO (February 21, 2018) – Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition, the marketing rights of additional consumer products have been licensed by Mission to MainPointe. As part of these transactions, the companies have also entered into a renewable Contract Manufacturing Agreement to continue manufacturing all of the included products that are currently made in Mission’s manufacturing facility. These agreements do not involve the...

3 Jan

Fabre-Kramer Partners with Mission Pharmacal for Future Commercial Manufacture of Novel Mechanism Antidepressant Travivo™ (Gepirone HCL) Tablets

Houston and San Antonio, TX (January 3, 2018) – Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) of Houston, TX, and Mission Pharmacal Company (Mission) of San Antonio, TX, announced today that they have signed agreements providing for Mission to complete the technology transfer to develop and manufacture the registration batches of Fabre-Kramer’s novel antidepressant, Travivo (gepirone HCl) Extended Release Tablets. Data from these batches will be used to support the submission of the NDA Amendment for Travivo to the Food and Drug Administration (FDA) for review and...

19 Dec

Alamo Pharma Services Leadership participates as a speaker and Sponsor of the recent FDA/CMS Summit in Washington, D.C.

DOYLESTOWN, Pa. (December 19, 2017) – Peter Marchesini, Chief Operating Officer of Alamo Pharma Services (“Alamo”), participated as one of two panelists in a session at the recent FDA/CMS Summit in Washington, D.C. The summit’s focus was to help attendees better understand the finer points of U.S. regulatory policy as it intersects with breakthrough scientific innovation. The annual conference hosted by KNect365, offers attendees the unique opportunity to learn the latest discoveries in drug programs and also receive formulary guidance directly from decision-makers.

24 Oct

Mission Pharmacal General Counsel gains national recognition for innovative ethics and compliance training with musical comedy

Ethics Follies® is a musical comedy which parodies popular Broadway shows and popular music. The original scripts are presented to licensed professionals and corporate executives as ethics training. The Association of Corporate Counsel (ACC), South/Central Texas Chapter, produces the original musical each year and was presented the “Outstanding Chapter Achievement Award for Innovative Programming” by the ACC in Washington, D.C. The award was announced at the ACC Annual Meeting Award Ceremony on Tuesday, October 17, 2017.

19 Oct

Savvy Companies Outside Pharmaceutical Industry Realizing Benefits of Partnering with BexR Logistix

BexR Logistix, LLC (“BexR”) is a full-service, U.S.-based, third-party Logistics Provider (3PL) and telesales organization that supplies a complete spectrum of a premiere, secure logistical support, and management services. Formed as the logistics and warehousing arm of parent company Mission Pharmacal Company (“Mission”), BexR’s roots lie squarely in pharmaceuticals. The sophistication and regulatory demands required to operate in that arena, however, have led clients from a wide variety of industries to discover the benefits of partnering with BexR.

19 Sep

Fewer than half of U.S. women take recommended vitamins prior to pregnancy, according to March of Dimes new Prenatal Health & Nutrition Survey

WHITE PLAINS, N.Y., (September 19, 2017) – Women of childbearing age need more education to ensure their own health and that of their babies both before and during pregnancy, according to findings from the new Prenatal Health & Nutrition survey of U.S. women announced today by the March of Dimes. While 97 percent of women 18-45 who have been or are currently pregnant reported taking prenatal vitamins or multivitamins during their current or last pregnancy, only 34 percent said they started taking the prenatal vitamin or multivitamin before they knew they were pregnant...